Skip to content

Investigating the effect of early medical treatment with enoxaparin on the rate of successful fertility following assisted reproductive methods

Investigating the effect of early medical treatment with enoxaparin on the rate of successful fertility following assisted reproductive methods in comparison to assisted reproductive methods without early use of enoxaparin in Kamali Medical Education Center in 1402-1401

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220530055028N1
Enrollment
90
Registered
2023-01-30
Start date
2023-03-11
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility

Interventions

Intervention 1: Intervention group: The intervention group of patients undergoing ART at the time of embryo transfer is given subcutaneous enoxaparin at a dose of 1 mg/kg/day/sc, which continues for a

Sponsors

Karaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age between 20-40 years BMI body mass index between 18-30 Having an egg suitable for fertilization Having a suitable endometrium with a diameter greater than 7 mm

Exclusion criteria

Exclusion criteria: Not having a specific medical disease that affects the study. Not taking enoxaparin chronically before the study for any reason Not having a specific coagulation disease such as platelet deficiency History of previous abortion History of successful pregnancy

Design outcomes

Primary

MeasureTime frame
Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: Serum BhCG level.;Clinical pregnancy. Timepoint: 5 weeks after transfer. Method of measurement: Sonography.

Secondary

MeasureTime frame
Abortion. Timepoint: Before the 20th week of pregnancy. Method of measurement: Sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrnaz Raeisidehkordi

Karaj University of Medical Sciences

mraeisi283@gmail.com+98 26 3446 0708

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026